Prospective Observational Study on the Ameliorating Effects of Imeglimin on Blood Glucose Spikes and Vascular Endothelial Function

Prospective Observational Study on the Ameliorating Effects of Imeglimin on Blood Glucose Spikes and Vascular Endothelial Function - Prospective Observational Study on the Ameliorating Effects of Imeglimin on Blood Glucose Spikes and Vascular Endothelial Function

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046311

Enrollment

Registered

2023-01-13

Start date

2021-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes on diet and exercise therapy alone or on treatment with one or two oral hypoglycemic agents who need to be treated with imegurimine

Exclusion criteria

Exclusion criteria: (1) Patients with contraindications to Twimig (2) Patients who are judged by the researcher to be inappropriate as research subjects

Design outcomes

Primary

Measure	Time frame
Change in vascular endothelial function from baseline to week 12	—

Countries

Japan

Contacts

Public ContactTaisuke Uchida

Faculty of Medicine, University of Miyazaki Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine

taisuke_uchida@med.miyazaki-u.ac.jp0985-85-9121

Outcome results